Browse All
Displaying 271 - 275 of 348
Author:Hauser, Robert Bergmans, Bruno Malaty, Irene Cobb, Daniel Homola, Jaclyn Bergmann, Lars Gupta, Resmi Jia, Jia Shah, Megha Chaudhuri, K Ray
Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials
Topic:Movement Disorders
Program Number:P9.005
Author Institution:University of South Florida, Tampa, FL, USA, Tampa, FL AZ St-Jan Brugge-Oostende AV, Brugge, Belgium and Ghent University Hospital, Ghent, Belgium, Bruges, Belgium University of Florida, Gainesville, FL, USA, Gainesville, FL Neurological Center of North Georgia, LLC, Gainesville, GA, USA, Gainesville, GA AbbVie Inc., North Chicago, IL, USA, Elk Grove Village, IL AbbVie Inc., North Chicago, IL, USA, Ludwigshafen, Germany AbbVie Inc., North Chicago, IL, USA, Sugar Land, TX AbbVie Inc., North Chicago, IL, USA, Lincolnshire, IL AbbVie Inc., North Chicago, IL, USA, Detroit, MI King's College Hospital, London, UK, London, United Kingdom
Author:Slatko, Gary Wargacki, Stephen Rogawski, Michael
Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications
Topic:Epilepsy/Clinical Neurophysiology (EEG)
Program Number:P9.006
Author Institution:Aquestive Therapeutics, Warren, NJ University of California - Davis, Sacramento, CA
Author:Freeman, Jason Delgado, Silvia Alvarez, Enrique Thouvenot, Eric Okai, Annette Bhatt, Alit Wei, Wenjia Ziemssen, Tjalf
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Author Institution:Novartis Pharmaceuticals, USCDMA , East Hanover , NJ University of Miami Miller School of Medicine, Miami, FL University of Colorado School of Medicine, Aurora, CO CHU Nîmes, Univ Montpellier, Nîmes, France North Texas Institute of Neurology and Headache, Plano, TX Novartis Healthcare Pvt. Ltd., Hyderabad, India Novartis Pharma AG, Basel, Switzerland University Clinic Carl-Gustav Carus, Dresden, Germany
Author:Yano, Chikashi Matsuura, Eiji Nakamura, Tomonori Ando, Masahiro Hiramatsu, Yu Nozuma, Satoshi Higuchi, Yujiro Sakiyama, Yusuke Hashiguchi, Akihiro Michizono, Kumiko Higashi, Keiko Takashima, Hiroshi
Session Name:P9: Autoimmune Neurology: MOGAD
Topic:Autoimmune Neurology
Program Number:P9.007
Author Institution:Kagoshima University, Kagoshima-ken, Kagoshima-shi, Japan
Author:Bar-Or, Amit Wiendl, Heinz De Seze, Jerome Correale, Jorge Cross, Anne Derfuss, Tobias Selmaj, Krzysztof Winthrop, Kevin Giacomini, Paul Sacca, Francesco Hu, Xixi Sullivan, Roseanne Jehl, Valentine Boer, Ibolya Bhatt, Alit Hauser, Stephen
Author Institution:Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA University of Muenster, Muenster, Germany University Hospital of Strasbourg, Strasbourg, France Institute for Neurological Research Dr. Raul Carrea, Buenos Aires, Argentina Washington University School of Medicine, Clayton, MO Neurology Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine and Biomedicine, University Hospital and University of Basel, Basel, Switzerland Center for Neurology, Lodz, Lodz, Poland Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada NSRO Department, University “Federico II” of Naples, Naples, Italy Novartis Pharmaceuticals Corporation, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland Novartis Healthcare Pvt. Ltd., Hyderabad, India UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA
